Anna Mudge - October 29, 2024 GENE-ius options to protect gene therapies Gene therapies involve treating patients by manipulating their genetic makeup. Such therapies may ...
Joanna Smith - October 4, 2023 Congratulations to our Rising Stars 2023 Congratulations to Eleanor Maciver, Anna Mudge and Ben Tolley for being recognised as Rising Stars ...
Anna Mudge - August 9, 2023 The next-generation therapies for autoimmune diseases The immune system has an extraordinary capacity to distinguish “self” from “non-self”. This means ...
Anna Mudge - May 4, 2023 The allogeneic advantage Bespoke cell therapies are expensive and time-consuming. Now allogeneic cell treatments offer a ...
Anna Mudge - March 21, 2023 Advanced Therapies Congress 2023 - five key themes Anna Mudge enjoyed a bustling two days at the Advanced Therapies Congress 2023 in London. Nine ...
Jacqueline Murphy - March 7, 2023 Come and join us for a ‘Celebration of all things Singapore’ We are excited to be in Singapore for INTA 2023 and very much hope that you can join us at our ...
Anna Mudge - February 20, 2023 Trafficking T cells – how to get cells to their target destination After being in the shadow of its famous relative, the antibody-producing B cell, for many decades, ...
Jacqueline Murphy - October 5, 2022 Congratulations to our Rising Stars 2022 Congratulations to Eleanor Maciver, Anna Mudge and Ben Tolley for being recognised as Rising Stars ...
Anna Mudge - May 24, 2022 Recipe for success - intellectual property opportunities in future food The future of food is big business and it’s only going to get bigger as both technology and ...
Victoria Coleman - February 10, 2022 International Day of Women and Girls in Science 2022 As a forward-looking intellectual property firm working at the forefront of innovation, we know how ...
Anna Mudge - October 9, 2020 Minimally invasive, maximum potential: liquid biopsy is redefining diagnosis Many of us will know someone who has undergone a biopsy during a medical diagnosis: we may even ...
Anna Mudge - March 31, 2020 Neoantigen-targeted adoptive cell therapies – the next frontier in cancer immunotherapy Cancer immunotherapies harness the power of the patient’s immune system to destroy malignant cells ...
Anna Mudge - February 21, 2020 2020 BioInfect Conference - tackling antimicrobial resistance Antimicrobial resistance (AMR) poses a global threat. No new classes of antibiotics have been ...
Anna Mudge - February 19, 2020 What makes Massachusetts small but mighty? Deirdre Sanders, president of the Boston Patent Law Association and a principle at Hamilton Brook ...
Richard Clegg - February 12, 2020 Oppositions & Appeals: we opened the door for different types of data to support a medical use Case 4 - T 801/06 (EPO Board of Appeal, 4 March 2009)
Anna Mudge - December 18, 2019 Will biomarkers come of age? The world’s population is ageing. In 2018, for the first time in history, people aged 65 or above ...
Anna Mudge - November 27, 2019 Biomarkers and precision medicine A biomarker, an amalgamation of the term ‘biological marker’, is a measurable indicator of a ...
Anna Mudge - June 19, 2019 Tips from the top: inspiring women in technology You may be surprised to hear that only 17% of those working in Technology in the UK are female. ...
Anna Mudge - December 2, 2018 The importance of Innovation Hubs in the UK's North West Region Life science ‘start-ups’, ‘spin-outs’ and SMEs are some of the most innovative businesses and are ...
Anna Mudge - April 20, 2018 Celebrating women working in IP in the North West On Thursday 19 April, we were proud hosts of an American Intellectual Property Law Association ...
